LEADER 03999nam  22005175  450 
001 9910300323403321
005 20251116194810.0
010   $a3-319-57580-5
024 7 $a10.1007/978-3-319-57580-3
035   $a(CKB)4100000001040944
035   $a(DE-He213)978-3-319-57580-3
035   $a(MiAaPQ)EBC5144768
035   $a(PPN)221253998
035   $a(EXLCZ)994100000001040944
100   $a20171112d2018      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFundamentals of Nuclear Pharmacy /$fby Gopal B. Saha
205   $a7th ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (XVII, 428 p. 110 illus., 31 illus. in color.)
311 08$a3-319-57579-1 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aThe Atom -- Radioactive Decay -- Instruments for Radiation Detection and Measurement -- Production of Radionuclides -- Radionuclide Generators -- Radiopharmaceuticals and Methods of Radiolabeling -- Characteristics of Specific Radiopharmaceuticals -- Quality Control of Radiopharmaceuticals -- Nuclear Pharmacy -- Internal Radiation Dosimetry -- Radiation Regulations, Protection, and Uses -- In Vitro and In Vivo Nonimaging Tests -- Diagnostic Uses of Radiopharmaceuticals in Nuclear Medicine -- Molecular Imaging -- Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine -- Adverse Reactions to and Altered Biodistribution of Radiopharmaceuticals.
330   $aCurrently an estimated 17 million nuclear medicine procedures are performed each year in the US and constantly evolving, as new radiopharmaceuticals and imaging techniques are introduced for better diagnosis and treatment of human diseases. In keeping up with new developments, the Seventh Edition of Fundamentals of Nuclear Pharmacy chronicles the advancements in radiopharmaceuticals and their use in clinical applications. It discusses basic concepts such as the atom, radioactive decay, instrumentation and production of radionuclides, and explores the design, labeling, characteristics and quality control of radiopharmaceuticals. Radiation regulations and diagnostic and therapeutic applications of radiopharmaceuticals are detailed. Thoroughly updated, the Seventh Edition includes new topics such as alternative productions of 99Mo; production of 64Cu, 86Y, 89Zr, 177Lu, 223Ra; synthesis and clinical uses of new radiopharmaceuticals such as DaTscan, Xofigo, Amyvid, Neuraceq, Vizamyl, Axumin and 68Ga-DOTATATE; dosimetry of new radiopharmaceuticals; theranostic agents and translational medicine. It features numerous examples, diagrams, and images to further clarify the information and offers end- of-chapter questions to help readers assess their comprehension of the material. Recognized as a classic text on nuclear chemistry and pharmacy and acclaimed for its concise and easy-to-understand presentation, Fundamentals of Nuclear Pharmacy is an authoritative resource for nuclear medicine physicians, residents, students, and technologists. .
606   $aNuclear medicine
606   $aPharmacy
606   $aRadiotherapy
606   $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
606   $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056
615  0$aNuclear medicine.
615  0$aPharmacy.
615  0$aRadiotherapy.
615 14$aNuclear Medicine.
615 24$aPharmacy.
615 24$aRadiotherapy.
676   $a616.07548
700   $aSaha$b Gopal B.$4aut$4http://id.loc.gov/vocabulary/relators/aut$0520745
906   $aBOOK
912   $a9910300323403321
996   $aFundamentals of Nuclear Pharmacy$91744615
997   $aUNINA